Closed
Source verified April 21, 2026
PSC Partners Canada Annual Research Grant Program
Research funding for PSC-related studies
Latest source updateLast Update: June 30, 2026Latest change: The research guidance page now shows a broader research hub with new contact information, while the Canada grants page still shows the same key dates and funding terms.View change
Latest source update
Last Update: June 30, 2026
Latest change: The research guidance page now shows a broader research hub with new contact information, while the Canada grants page still shows the same key dates and funding terms.
Research guidance and contact details updated
The Scientific/Medical Advisors source now presents a broader research initiatives hub instead of the earlier SMAC review-criteria content, and it adds the contact email research@pscpartners.org plus additional research and patient-participation links. On the Canada grants page, the 2025-2026 cycle dates remain unchanged: LOI opens August 18, 2025, LOI deadline is December 1, 2025, formal application deadline is February 1, 2026, reviews occur in February and March 2026, and awardees are announced in April or May 2026. The visible funding and eligibility language also remains the same, but the 2026 grant entry is now much shorter and no longer shows the linked abstract and detailed study summary.
Funding available
$ 37,500 - $ 100,000
Deadline
February 1, 2026
Location
Canada
Who can apply
To qualify for a Research Seed Grant, the primary investigator must be a researcher with preclinical and/or clinical expertise and be affiliated with an academic medical institution, research institution, or nonprofit/community-based organization.
See full eligibility
Overview
PSC Partners and affiliate PSC Partners Canada award annual research grants for PSC-related studies, with awards of up to $37,500 per year for two years or $50,000 per year for two years. The program supports basic science, preclinical, and clinical research on primary sclerosing cholangitis and closely associated diseases, and strongly encourages patient partnership in proposals.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible Funding
- Maximum amount : 100,000 $
- Minimum amount : 37,500 $
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Canadians
Non-profit candidates
Sector of operation
- Higher Education
- Research
- Hospitals and Rehabilitation
- Other Health Services
Target groups
- Nonprofits / charities
- Academia / students
Revenue structures
- 100% donations / grants
Scope
- National
- International
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Basic science research.
- Preclinical research, including animal models, human tissue, and organoids.
- Clinical research, including interventional, non-interventional, and social sciences.
- Research related to primary sclerosing cholangitis and closely associated diseases such as inflammatory bowel diseases and cholangiocarcinoma.
Documents Needed
- Letter of Intent Form
Official resources
Eligibility
Who is eligible?
- To qualify for a Research Seed Grant, the primary investigator must be a researcher with preclinical and/or clinical expertise and be affiliated with an academic medical institution, research institution, or nonprofit/community-based organization.
- To qualify for the Young Investigator Award, the primary investigator must be in training or within five years of their last training position or degree, have completed an advanced terminal degree, be affiliated with an academic medical institution, research institution, or nonprofit/community-based organization, and have a mentor or be willing to work with one if needed for the project.
Who is not eligible
- Pharmaceutical, biotech, or related industries are not eligible for funding through this program.
Ineligible Costs and Activities
- Pharmaceutical, biotech, or related industries are not eligible for funding through this program.
Eligible geographic areas
- Canada.
- Prescribed universities outside Canada.
Selection criteria
- All applications are reviewed using the same scoring criteria.
- Patient partnership is one of the components that Community Reviewers evaluate while scoring applications.
- PSC Partners reserves funding to select at least 1 clinical grant.
- Multiple submissions from the same institution will be considered, with priority given to supporting a breadth of applicants from a variety of institutions.
How to apply
- Prospective applicants should click the link and follow the instructions to create a new account or log in.
- Prospective applicants will be routed directly to the LOI for PSC Partners & PSC Partners Canada Research Seed Grants.
- Make sure to press the SAVE button as you work on the LOI.
- All prospective applicants must submit the Letter of Intent Form.
Processing and Agreement
- Upon submission of the Letter of Intent, allow approximately two weeks for the PSC Partners team to respond.
- If eligibility is determined, detailed application instructions will be provided to the applicant directly.
Additional information
- Patient partnership is strongly encouraged in research proposals.
- Grant selections are limited to 1 grant per department or division within the same institution.
- Multiple submissions from the same institution will be considered, with priority given to supporting a breadth of applicants from a variety of institutions.
- The grants cycle is closed and 2026 awards will be announced this summer.
Contacts
Frequently Asked Questions about the PSC Partners Canada Annual Research Grant Program Program
What is the PSC Partners Canada Annual Research Grant Program?
PSC Partners and affiliate PSC Partners Canada award annual research grants for PSC-related studies, with awards of up to $37,500 per year for two years or $50,000 per year for two years. The program supports basic science, preclinical, and clinical research on primary sclerosing cholangitis and closely associated diseases, and strongly encourages patient partnership in proposals.
How much funding can be received?
PSC Partners Canada Annual Research Grant Program Funds up to $100,000 of admissible expenses.
Who is eligible for the PSC Partners Canada Annual Research Grant Program program?
To be eligible for the PSC Partners Canada Annual Research Grant Program program, you must:
The primary investigator must meet the program's degree and training requirements.
The primary investigator must be affiliated with an academic medical institution, research institution, or nonprofit/community-based organization.
The primary investigator must have preclinical and/or clinical research expertise, depending on the award type.
What expenses are eligible under PSC Partners Canada Annual Research Grant Program?
Basic science research.
Preclinical research, including animal models, human tissue, and organoids.
Clinical research, including interventional, non-interventional, and social sciences.
Research related to primary sclerosing cholangitis and closely associated diseases such as inflammatory bowel diseases and cholangiocarcinoma.
Who can I contact for more information about the PSC Partners Canada Annual Research Grant Program?
You can contact PSC Partners Seeking a Cure Canada (PSC) by email at grants@pscpartners.org or by phone at 303-771-5227.
Where is the PSC Partners Canada Annual Research Grant Program available?
The PSC Partners Canada Annual Research Grant Program program is available across Canada.
Is the PSC Partners Canada Annual Research Grant Program a grant, loan, or tax credit?
PSC Partners Canada Annual Research Grant Program is a Researchers And Facilities